Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Pfizer and ASKA Pharmaceutical Announce Co-promotion of RSV Vaccine "ABRYSVO Intramuscular Injection"
Personnel Change of ASKA Pharmaceutical
Notice regarding Introduction of Restricted Stock Incentive Plan for Employee Stock Ownership Association
Notice regarding Transition to Company with Audit Committee
Personnel Changes of ASKA Pharmaceutical
Personnel Change of ASKA Pharmaceutical Holdings
Teijin Pharma and ASKA Pharmaceutical Enter Joint Research Agreement to Accelerate Discovery of Novel Small-Molecule Drug Candidates for Gynecological
ASKA Pharma, Apr-Dec (Cumulative 3Q) Ordinary Profit Decreases by 11%
Consolidated Financial Results for the Third Quarter of FY2025
Supplementary Documents of Consolidated Financial Results for the Third Quarter of FY2025
ASKA Achieves Score of B in Climate Change B- in Water Security and C in Forests at CDP2025
ASKA Pharmaceutical Launches LEUPRORELIN ACETATE SR FOR INJECTION KIT
ASKA Pharmaceutical Holdings Participates in Jefferies Global Healthcare Conference in London
PPMX and ASKA Pharmaceutical Sign Joint Research Agreement to Aim to Create New Antibody Drugs
Supplementary Documents for 2Q FY2025
Notice of Revisions to the Forecast of Consolidated Financial Results for FY2025
Consolidated Financial Results for the Second Quarter of FY2025
ASKA Pharma, Ordinary Profit Forecast for the Fiscal Year Revised Downward by 12%
(Correction) Partial Correction to Summary of Consolidated Financial Results for the First Quarter of FY2025
(Correction) Partial Correction to Supplementary Documents of Consolidated Financial Results for the First Quarter of FY2025